USG Awards Pharmaceutical Company Funds To Develop Ebola Treatment

The Hill: Feds award company up to $35M to develop Ebola drug
“The Department of Health and Human Services (HHS) on Tuesday awarded about $12 million to a North Carolina pharmaceutical company that has been developing Ebola treatments. The company, BioCryst Pharmaceuticals, has created a ‘promising’ experimental drug that prevents the Ebola virus from reproducing; it has been effective in preliminary studies, according to a release Tuesday…” (Ferris, 3/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.